You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 19, 2024

Details for New Drug Application (NDA): 022156


✉ Email this page to a colleague

« Back to Dashboard


NDA 022156 describes CLEVIPREX, which is a drug marketed by Chiesi and is included in one NDA. It is available from two suppliers. There are three patents protecting this drug. Additional details are available on the CLEVIPREX profile page.

The generic ingredient in CLEVIPREX is clevidipine. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the clevidipine profile page.
Summary for 022156
Tradename:CLEVIPREX
Applicant:Chiesi
Ingredient:clevidipine
Patents:3
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for 022156
Generic Entry Date for 022156*:
Constraining patent/regulatory exclusivity:
Dosage:
EMULSION;INTRAVENOUS

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Pharmacology for NDA: 022156
Mechanism of ActionCalcium Channel Antagonists
Suppliers and Packaging for NDA: 022156
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CLEVIPREX clevidipine EMULSION;INTRAVENOUS 022156 NDA Chiesi USA, Inc. 10122-610 10122-610-10 10 CARTON in 1 CARTON (10122-610-10) / 1 VIAL, SINGLE-USE in 1 CARTON (10122-610-01) / 50 mL in 1 VIAL, SINGLE-USE
CLEVIPREX clevidipine EMULSION;INTRAVENOUS 022156 NDA Chiesi USA, Inc. 10122-611 10122-611-10 10 CARTON in 1 CARTON (10122-611-10) / 1 VIAL, SINGLE-USE in 1 CARTON (10122-611-01) / 100 mL in 1 VIAL, SINGLE-USE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:EMULSION;INTRAVENOUSStrength25MG/50ML (0.5MG/ML)
Approval Date:Aug 1, 2008TE:RLD:Yes
Patent:⤷  Sign UpPatent Expiration:Oct 10, 2031Product Flag?YSubstance Flag?Delist Request?
Patent:⤷  Sign UpPatent Expiration:Oct 10, 2031Product Flag?YSubstance Flag?Delist Request?
Patent:⤷  Sign UpPatent Expiration:Oct 10, 2031Product Flag?YSubstance Flag?Delist Request?

Expired US Patents for NDA 022156

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Chiesi CLEVIPREX clevidipine EMULSION;INTRAVENOUS 022156-001 Aug 1, 2008 ⤷  Sign Up ⤷  Sign Up
Chiesi CLEVIPREX clevidipine EMULSION;INTRAVENOUS 022156-002 Aug 1, 2008 ⤷  Sign Up ⤷  Sign Up
Chiesi CLEVIPREX clevidipine EMULSION;INTRAVENOUS 022156-001 Aug 1, 2008 ⤷  Sign Up ⤷  Sign Up
Chiesi CLEVIPREX clevidipine EMULSION;INTRAVENOUS 022156-002 Aug 1, 2008 ⤷  Sign Up ⤷  Sign Up
Chiesi CLEVIPREX clevidipine EMULSION;INTRAVENOUS 022156-003 Nov 8, 2013 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.